Literature DB >> 19584759

Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?

Tracey H Sach1, Garry R Barton, Claire Jenkinson, Michael Doherty, Anthony J Avery, Kenneth R Muir.   

Abstract

BACKGROUND: A number of different measures can be used within cost-utility analyses, we compared results according to both the EQ-5D and SF-6D.
METHODS: A randomized trial was conducted to compare 4 options for people with knee pain. Over the 2 year trial period, the change in cost to health-service was estimated, and both the EQ-5D and SF-6D were used to estimate the change in quality-adjusted life years (QALYs). Using a complete case analysis, the cost-utility (incremental cost-effectiveness ratio [ICER]) of each option, according to both the EQ-5D and SF-6D, was calculated and assessed in relation to the cost-effectiveness threshold of pound20,000 per QALY.
RESULTS: Of the 389 participants, 247 had complete cost, EQ-5D and SF-6D data. According to the EQ-5D, option 1 had an estimated ICER of pound10,815 (compared with option 4), option 2 was dominated by option 1, and option 3 was subject to extended dominance. Conversely, according to the SF-6D, option 3 had an ICER of pound9999 (compared with option 4), option 2 had an ICER of pound36,883 (compared with option 3), and option 1 was subject to extended dominance.
CONCLUSION: The EQ-5D and SF-6D estimated that different options (1 and 3, respectively) were cost-effective at the pound20,000 per QALY threshold, demonstrating that the choice of measure does matter.

Entities:  

Mesh:

Year:  2009        PMID: 19584759     DOI: 10.1097/MLR.0b013e3181a39428

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  27 in total

1.  Do modern total knee replacements offer better value for money? A health economic analysis.

Authors:  David F Hamilton; Nicholas D Clement; Richard Burnett; James T Patton; Mathew Moran; Colin R Howie; A H R W Simpson; Paul Gaston
Journal:  Int Orthop       Date:  2013-07-09       Impact factor: 3.075

2.  Comparison of EQ-5D and SF-6D utilities in Pompe disease.

Authors:  T A Kanters; W K Redekop; M E Kruijshaar; A T van der Ploeg; M P M H Rutten-van Mölken; L Hakkaart
Journal:  Qual Life Res       Date:  2014-10-24       Impact factor: 4.147

Review 3.  State-of-the-art: outcome assessment in adult spinal deformity.

Authors:  Jeffrey L Gum; Leah Y Carreon; Steven D Glassman
Journal:  Spine Deform       Date:  2020-10-09

4.  The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohort.

Authors:  Roisin Adams; Benjamin M Craig; Cathal D Walsh; Douglas J Veale; Barry Bresnihan; Oliver FitzGerald; Michael Barry
Journal:  Value Health       Date:  2011-07-08       Impact factor: 5.725

5.  SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.

Authors:  J C Davis; T Liu-Ambrose; K M Khan; M C Robertson; C A Marra
Journal:  Osteoporos Int       Date:  2011-09-10       Impact factor: 4.507

6.  Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).

Authors:  Fan Yang; Titus Lau; Evan Lee; A Vathsala; Kee Seng Chia; Nan Luo
Journal:  Eur J Health Econ       Date:  2014-12-18

7.  Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.

Authors:  Carmen Selva-Sevilla; Paula Ferrara; Manuel Gerónimo-Pardo
Journal:  Eur J Health Econ       Date:  2020-02-17

8.  Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.

Authors:  Yuanxi Jia; Li Li; Fuqiang Cui; Dongliang Zhang; Guomin Zhang; Fuzhen Wang; Xiaohong Gong; Hui Zheng; Zhenhua Wu; Ning Miao; Xiaojin Sun; Li Zhang; Jingjing Lv; Feng Yang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Quality of Life in Palliative Care.

Authors:  Mellar P Davis; David Hui
Journal:  Expert Rev Qual Life Cancer Care       Date:  2017-11-08

10.  Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease.

Authors:  Ting Zhou; Zhiyuan Chen; Hongchao Li; Feng Xie
Journal:  Med Decis Making       Date:  2021-04-03       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.